Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers.

Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers.

The iminosugar N-butyldeoxynojirimycin (NB-DNJ), an endoplasmic reticulum alpha-glucosidase inhibitor, has an antiviral effect against bovine viral diarrhea virus (BVDV). In this report, we investigate the molecular mechanism of this inhibition by studying the folding pathway of BVDV envelope glycop...

Full description

Bibliographic Details
Main Authors:	Branza-Nichita, N, Durantel, D, Carrouée-Durantel, S, Dwek, R, Zitzmann, N
Format:	Journal article
Language:	English
Published:	American Society for Microbiology 2001

Similar Items

Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus.
by: Durantel, D, et al.
Published: (2001)

Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus.
by: Durantel, D, et al.
Published: (2004)

The bovine viral diarrhoea virus: a model for the study of antiviral molecules interfering with N-glycosylation and folding of envelope glycoprotein
by: Durantel, D, et al.
Published: (2015)

Role of disulfide bond formation in the folding and assembly of the envelope glycoproteins of a pestivirus.
by: Branza-Nichita, N, et al.
Published: (2002)

Targeting the host ER alpha glucosidases I and II as antiviral therapy
by: Branza-Nichita, N, et al.
Published: (2007)

Long alkylchain iminosugars block the HCV p7 ion channel
by: Pavlovic, D, et al.
Published: (2005)

The pestivirus E(rns) glycoprotein interacts with E2 in both infected cells and mature virions.
by: Lazar, C, et al.
Published: (2003)

Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
by: Lazar, C, et al.
Published: (2007)

Iminosugars in combination with interferon and ribavirin permanently eradicate noncytopathic bovine viral diarrhea virus from persistently infected cells.
by: Woodhouse, S, et al.
Published: (2008)

Long chain N-alkyl compounds and Oxa-derivatives thereof and use antiviral compositions
by: Zitzmann, N, et al.
Published: (2001)

Bypass of quality control in protein folding pathways induces specific misfolding of HIV envelope V2 loop: implications for iminosugars as antivirals
by: Spiro, S, et al.
Published: (2014)

Cholesterol depletion of hepatoma cells impairs hepatitis B virus envelopment by altering the topology of the large envelope protein
by: Dorobantu, C, et al.
Published: (2011)

N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery.
by: Pollock, S, et al.
Published: (2008)

Role of N-glycan trimming in the folding and secretion of the pestivirus protein E(rns)
by: Branza-Nichita, N, et al.
Published: (2004)

Virus morphogenesis and viral entry as alternative targets for novel hepatitis C antivirals
by: Chapel, C, et al.
Published: (2006)

Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors.
by: Chapel, C, et al.
Published: (2007)

Glucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particles
by: Chapel, C, et al.
Published: (2006)

Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells.
by: Macovei, A, et al.
Published: (2010)

Long chain n-alkyl compounds and oxa-derivatives thereof
by: Zitzmann, N, et al.
Published: (2016)

Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus.
by: Longxing Cao, et al.
Published: (2019-05-01)

Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles.
by: Chapel, C, et al.
Published: (2006)

Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: Implications for the development of broad spectrum anti-hepatitis virus agents
by: Zitzmann, N, et al.
Published: (1999)

NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin.
by: Jeyakumar, M, et al.
Published: (2004)

Long-term non-hormonal male contraception in mice using N-butyldeoxynojirimycin.
by: Walden, C, et al.
Published: (2006)

Brefeldin A inhibits pestivirus release from infected cells, without affecting its assembly and infectivity.
by: Macovei, A, et al.
Published: (2006)

Discovery of Novel Bovine Viral Diarrhea Inhibitors Using Structure-Based Virtual Screening on the Envelope Protein E2
by: Mariela Bollini, et al.
Published: (2018-03-01)

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
by: Andersson, U, et al.
Published: (2000)

N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice.
by: Priestman, D, et al.
Published: (2008)

A β-Hairpin Motif in the Envelope Protein E2 Mediates Receptor Binding of Bovine Viral Diarrhea Virus
by: Fernando Merwaiss, et al.
Published: (2021-06-01)

Liposome treatment of viral infections
by: Dwek, R, et al.
Published: (2011)

Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells.
by: Pollock, S, et al.
Published: (2010)

Innate Antiviral Immune Responses to Hepatitis B Virus
by: David Durantel, et al.
Published: (2010-07-01)

Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment.
by: Heare, T, et al.
Published: (2007)

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.
by: Cox, T, et al.
Published: (2000)

Hepatitis C virus E2 envelope glycoprotein produced in Nicotiana benthamiana triggers humoral response with virus-neutralizing activity in vaccinated mice
by: Dobrica, M, et al.
Published: (2021)

Structural and Biophysical Characterization of the HCV E1E2 Heterodimer for Vaccine Development
by: Eric A. Toth, et al.
Published: (2021-05-01)

A Biologically-validated HCV E1E2 Heterodimer Structural Model
by: Matteo Castelli, et al.
Published: (2017-03-01)

ANTIVIRAL COMPOUNDS AND PREPARATIONS EFFECTIVE AGAINST BOVINE VIRAL DIARRHEA
by: T. I. Glotova, et al.
Published: (2017-10-01)

The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.
by: Fischer, P, et al.
Published: (1995)

Morphology and Molecular Composition of Purified Bovine Viral Diarrhea Virus Envelope.
by: Nathalie Callens, et al.
Published: (2016-03-01)